Hunter RL - Search Results

1

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis.

Brown RE, Hunter RL, Hwang SA. Brown RE, et al. Among authors: hunter rl. Front Immunol. 2017 Feb 2;8:78. doi: 10.3389/fimmu.2017.00078. eCollection 2017. Front Immunol. 2017. PMID: 28210262 Free PMC article.

2

Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.

Hwang SA, Wilk KM, Budnicka M, Olsen M, Bangale YA, Hunter RL, Kruzel ML, Actor JK. Hwang SA, et al. Among authors: hunter rl. Vaccine. 2007 Sep 17;25(37-38):6730-43. doi: 10.1016/j.vaccine.2007.07.005. Epub 2007 Jul 27. Vaccine. 2007. PMID: 17698261 Free PMC article.

3

Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities.

Hunter RL, Actor JK, Hwang SA, Karev V, Jagannath C. Hunter RL, et al. Ann Clin Lab Sci. 2014 Fall;44(4):365-87. Ann Clin Lab Sci. 2014. PMID: 25361920

4

Hypoxia Sensing and Persistence Genes Are Expressed during the Intragranulomatous Survival of Mycobacterium tuberculosis.

Hudock TA, Foreman TW, Bandyopadhyay N, Gautam US, Veatch AV, LoBato DN, Gentry KM, Golden NA, Cavigli A, Mueller M, Hwang SA, Hunter RL, Alvarez X, Lackner AA, Bader JS, Mehra S, Kaushal D. Hudock TA, et al. Among authors: hunter rl. Am J Respir Cell Mol Biol. 2017 May;56(5):637-647. doi: 10.1165/rcmb.2016-0239OC. Am J Respir Cell Mol Biol. 2017. PMID: 28135421 Free PMC article.

5

Pathogenesis and Animal Models of Post-Primary (Bronchogenic) Tuberculosis, A Review.

Hunter RL, Actor JK, Hwang SA, Khan A, Urbanowski ME, Kaushal D, Jagannath C. Hunter RL, et al. Pathogens. 2018 Feb 6;7(1):19. doi: 10.3390/pathogens7010019. Pathogens. 2018. PMID: 29415434 Free PMC article. Review.

6

Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Nguyen TKT, d'Aigle J, Chinea L, Niaz Z, Hunter RL, Hwang SA, Actor JK. Nguyen TKT, et al. Among authors: hunter rl. Am J Pathol. 2020 Feb;190(2):286-294. doi: 10.1016/j.ajpath.2019.10.006. Epub 2019 Nov 14. Am J Pathol. 2020. PMID: 31734231 Free PMC article.

7

The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.

Brown RE, Hunter RL. Brown RE, et al. Among authors: hunter rl. Ann Clin Lab Sci. 2020 Mar;50(2):287-288. Ann Clin Lab Sci. 2020. PMID: 32366572 No abstract available.

8

Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.

Brown RE, Wolf DA, Hunter RL, Zhao B, Buja LM. Brown RE, et al. Among authors: hunter rl. Ann Clin Lab Sci. 2020 May;50(3):308-313. Ann Clin Lab Sci. 2020. PMID: 32581017

9

Morphoproteomics Identifies the Foamy Alveolar Macrophage as an M2 Phenotype with PD-L1 Expression in the Early Lesion of Post-Primary Tuberculosis: Implications for Host Immune Surveillance and Therapy.

Hwang SA, Ali Y, Fedotova E, Hunter RL, Brown RE. Hwang SA, et al. Among authors: hunter rl. Ann Clin Lab Sci. 2020 Jul;50(4):429-438. Ann Clin Lab Sci. 2020. PMID: 32826237

10

Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies.

Brown RE, Hunter RL. Brown RE, et al. Among authors: hunter rl. Pathogens. 2021 Dec 2;10(12):1572. doi: 10.3390/pathogens10121572. Pathogens. 2021. PMID: 34959527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page